BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2021 6:43:04 AM | Browse: 627 | Download: 1372
 |
Received |
|
2021-02-26 21:25 |
|
Peer-Review Started |
|
2021-02-26 21:33 |
|
First Decision by Editorial Office Director |
|
2021-05-07 20:25 |
|
Return for Revision |
|
2021-05-07 20:25 |
|
Revised |
|
2021-05-19 20:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-08-09 02:29 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-08-09 05:39 |
|
Articles in Press |
|
2021-08-09 05:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-19 15:20 |
|
Publish the Manuscript Online |
|
2021-08-23 06:43 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Adjuvant therapy for lung neuroendocrine neoplasms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Robert A Ramirez, Katharine Thomas, Aasems Jacob, Karen Lin, Yvette Bren-Mattison and Aman Chauhan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Robert A Ramirez, Consultant, FACP, Associate Professor, Department of Medicine-Division of Hematology/Oncology, Vanderbilt University Medical Center, 2220 Pierce Ave, 7770 Preston Research Building, Nashville, TN 37232, United States. robert.ramirez@vumc.org |
| Key Words |
Neuroendocrine; Adjuvant therapy; Lung; Pulmonary carcinoid; Small cell lung cancer |
| Core Tip |
Neuroendocrine neoplasms of the lung are uncommon malignancies. They vary in degrees of aggressiveness from the slow growing typical carcinoid tumors to the very fast-growing small cell lung cancer. While surgical resection should be considered for early-stage disease, the role of adjuvant therapy is less well established. Guidelines from different organizations vary, citing a lack of trials to support a high-level recommendation. This manuscript will discuss the evidence for and against adjuvant therapy in neuroendocrine neoplasms of the lung. |
| Publish Date |
2021-08-23 06:43 |
| Citation |
Ramirez RA, Thomas K, Jacob A, Lin K, Bren-Mattison Y, Chauhan A. Adjuvant therapy for lung neuroendocrine neoplasms. World J Clin Oncol 2021; 12(8): 664-674
|
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i8/664.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i8.664 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
